| Current Price | $23.48 | Mkt Cap | $7.2B |
|---|---|---|---|
| Open | $0.00 | P/E Ratio | 24.27 |
| Prev. Close | $23.48 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.00 - $0.00 | Volume | 1,383,552 |
| 52-Wk Range | $13.67 - $27.80 | Avg. Daily Vol. | 2,904,691 |
A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.
| Current Price | $23.48 | Mkt Cap | $7.2B |
|---|---|---|---|
| Open | $0.00 | P/E Ratio | 24.27 |
| Prev. Close | $23.48 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.00 - $0.00 | Volume | 1,383,552 |
| 52-Wk Range | $13.67 - $27.80 | Avg. Daily Vol. | 2,904,691 |
The best Bull and Bear pitches based on recency and number of recommendations.
I often eschew Biotech at this point in history because the investments hinge on single do or die events like FDA approval. It reminds me of a Red OR Black bet on a craps table. That being said Exelixis caught my attention due to its partnerships… More
This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.
Read the most recent pitches from players about EXEL.
Recs
TMFAdriaCimino
(55.60)
Submitted: 6/26/2020 9:09:05 AM :
Start Price:
$23.50
NASDAQ:EXEL Score:
-2.11
The company's lead molecule, cabozantinib, has the potential for four new indications in the next year or so. And revenue is already climbing at Exelixis thanks to this molecule for kidney and liver cancers.
Recs
DaytradingStars
(86.33)
Submitted: 6/2/2020 3:45:07 AM :
Start Price:
$24.62
NASDAQ:EXEL Score:
-6.41
25%+ A
Recs
poluh2k
(44.19)
Submitted: 11/8/2019 4:56:06 AM :
Start Price:
$15.28
NASDAQ:EXEL Score:
+52.36
Very good data
Find the members with the highest scoring picks in EXEL.
beave35 (79.51) Score: +1,656.10
The Score Leader is the player with the highest score across all their picks in EXEL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Playa14 | < 20 |
|
|
5Y | $1.27 | +1,748.82% | +49.69% | +1,699.13 | 0 Comment | |
| beave35 | 79.51 | 12/23/2014 |
|
5Y | $1.30 | +1,706.01% | +49.92% | +1,656.10 | 0 Comment | |
| tomkao | < 20 | 12/15/2014 |
|
5Y | $1.40 | +1,577.14% | +54.68% | +1,522.46 | 0 Comment | |
| jack0071 | 73.90 | 12/3/2014 |
|
5Y | $1.43 | +1,541.96% | +50.41% | +1,491.54 | 0 Comment | |
| portefeuille | 99.05 | 12/15/2014 |
|
5Y | $1.44 | +1,530.56% | +54.38% | +1,476.18 | 0 Comment | |
| akoniec | 35.69 | 10/9/2014 |
|
3Y | $1.55 | +1,414.84% | +58.82% | +1,356.02 | 0 Comment | |
| dcoyne13 | 44.36 | 9/16/2014 |
|
5Y | $1.62 | +1,349.29% | +55.98% | +1,293.31 | 0 Comment | |
| foolerhoff | 90.21 | 1/6/2015 |
|
5Y | $1.64 | +1,331.71% | +54.29% | +1,277.41 | 0 Comment | |
| new2fool23 | 44.32 | 1/5/2015 |
|
1Y | $1.67 | +1,305.99% | +52.72% | +1,253.27 | 0 Comment | |
| garisonmp3z | < 20 | 1/5/2015 |
|
5Y | $1.67 | +1,305.99% | +52.72% | +1,253.27 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
